title: Experience of ECMO in primary graft dysfunction after orthotopic heart transplantation.
abstract: BACKGROUND
  Primary graft dysfunction is the main cause of early mortality after heart transplantation. Mechanical circulatory support has been used to treat this syndrome.
  
  
  OBJECTIVE
  Describe the experience with extracorporeal membrane oxygenation to treat post-transplant primary cardiac graft dysfunction.
  
  
  METHODS
  Between January 2007 and December 2013, a total of 71 orthotopic heart transplantations were performed in patients with advanced heart failure. Eleven (15.5%) of these patients who presented primary graft dysfunction constituted the population of this study. Primary graft dysfunction manifested in our population as failure to wean from cardiopulmonary bypass in six (54.5%) patients, severe hemodynamic instability in the immediate postoperative period with severe cardiac dysfunction in three (27.3%), and cardiac arrest (18.2%). The average ischemia time was 151 ± 82 minutes. Once the diagnosis of primary graft dysfunction was established, we installed a mechanical circulatory support to stabilize the severe hemodynamic condition of the patients and followed their progression longitudinally.
  
  
  RESULTS
  The average duration of extracorporeal membrane oxygenation support was 76 ± 47.4 hours (range 32 to 144 hours). Weaning with cardiac recovery was successful in nine (81.8%) patients. However, two patients who presented cardiac recovery did not survive to hospital discharge.
  
  
  CONCLUSIONS
  Mechanical circulatory support with central extracorporeal membrane oxygenation promoted cardiac recovery within a few days in most patients.
authors.affiliation: Instituto de Cardiologia do Distrito Federal, Brasília, DF, BR.
authors.forename: Elson Borges
authors.initials: EB
authors.lastname: Lima
authors.affiliation: Instituto de Cardiologia do Distrito Federal, Brasília, DF, BR.
authors.forename: Claudio Ribeiro da
authors.initials: CR
authors.lastname: Cunha
authors.affiliation: Instituto de Cardiologia do Distrito Federal, Brasília, DF, BR.
authors.forename: Vitor Salvatore
authors.initials: VS
authors.lastname: Barzilai
authors.affiliation: Instituto de Cardiologia do Distrito Federal, Brasília, DF, BR.
authors.forename: Marcelo Botelho
authors.initials: MB
authors.lastname: Ulhoa
authors.affiliation: Instituto de Cardiologia do Distrito Federal, Brasília, DF, BR.
authors.forename: Maria Regina de
authors.initials: MR
authors.lastname: Barros
authors.affiliation: Instituto de Cardiologia do Distrito Federal, Brasília, DF, BR.
authors.forename: Camila Scatolin
authors.initials: CS
authors.lastname: Moraes
authors.affiliation: Instituto de Cardiologia do Distrito Federal, Brasília, DF, BR.
authors.forename: Letycia Chagas
authors.initials: LC
authors.lastname: Fortaleza
authors.affiliation: Instituto de Cardiologia do Distrito Federal, Brasília, DF, BR.
authors.forename: Nubia Wellerson
authors.initials: NW
authors.lastname: Vieira
authors.affiliation: Instituto de Cardiologia do Distrito Federal, Brasília, DF, BR.
authors.forename: Fernando Antibas
authors.initials: FA
authors.lastname: Atik
mesh_terms: D000293:Adolescent; D000328:Adult; D002315:Cardiopulmonary Bypass / Q000379:methods; D015199:Extracorporeal Membrane Oxygenation / Q000379:methods*; D005260:Female; D006333:Heart Failure / Q000601:surgery; D016027:Heart Transplantation / Q000009:adverse effects*; D006439:Hemodynamics; D017052:Hospital Mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D055031:Primary Graft Dysfunction / Q000601:surgery*; D012307:Risk Factors; D012720:Severity of Illness Index; D018709:Statistics, Nonparametric; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult